In vitro study of methanolic extract of Eclipta alba Hassk. FOR hepg2 cell line

Authors

  • Mangal Tathe

Keywords:

Eclipta alba Hassk., HepG2, (Sulforhodamine B) srb assay.

Abstract

Synthetic anticancer drugs, apart from their high cost are well known for their hazardous side effects. So identification of new anticancer herbal medicine, which should not be cost effective only, but should be in possession of good anti-cancer effects also, is the need of the day. Here we are presenting such an Ayurvedic herb which is used since centuries for the treatment of diseases of diverse origin.  Eclipta alba Hassk., also called as Bhrungraj is very important medicinal herb in different medicinal formulations. In Ayurveda Bhrungraj is well known drug especially for hair growth. Many researches from modern world have proved Bhrungraj as a prominent liver-corrective in last 40 years. In the ancient science of life, Bhrungraj is described in previous researches as in possession of regeneration of hepatic cells.

Here we are presenting all aspects about Bhrungraj in terms of qualitative and quantitative values and we have also tried to prove the anticancer activity of it. As mentioned earlier, it is traditionally used as a hepatoprotective agent.  for the evaluation of its effects on HepG2 (Human liver cancer cell line). The srb assay results were used to evaluate the anti-cancer activity of the extract.   The experiment revealed that the average percentage of growth inhibition was 77.36%. Cell viability srb assay also showed significant growth inhibition, at the same time statistical analysis of srb assay also proved significant results. The research performed here is very useful for set up of different extract studies of Bhrungraj for its anticancer activity.

Downloads

Download data is not yet available.

References

1. Organization, W. H. Cancer; 2018. Available from: http://www.who.int/news-room/factsheets/detail/cancer. Accessed June 29, 2019
2. Khalaf N, Ying J, Mittal S, et al. Natural history of untreated hepatocellular carcinoma in a US cohort and the role of cancer surveillance. Clin Gastroenterol Hepatol. 2017;15:273–281.e271. doi:10.1016/j.cgh.2016.07.033
3. Shri. Ba. G. Vaidhya ;Nighantu adarsh, Chaukhamba Bharati Akadami , Varanasi; 2nd edi. Sahdevyadi Varga, (1):764-769
4. Tanu Sharma, M.C. Sidhu.(2017), “ Cytomorphological and Preliminary Phytochemical Screening of Eclipta alba (L.) Hassk.” International Journal of Green Pharmacy; 11(1): S23.
5. Sabri et. al. (2012), “ Phytochemical Screening and identification of some compounds from Mallow.” J. Nat. Plant Resource ., 2012,2 (4) : 512-516.
6. Kumar, S., & Dhanani, T. (2013). Development and validation of a rapid high performance liquid chromatography - photodiode array detection method for estimation of a bioactive compound wedelolactone in extracts of Eclipta alba. Brazilian Journal of Pharmaceutical Sciences, 49(1), 57–63. doi:10.1590/s1984-82502013000100007
7. Orellana, E., & Kasinski, A. (2016). Sulforhodamine B (SRB) Assay in Cell Culture to Investigate Cell Proliferation. BIO-PROTOCOL, 6(21). doi:10.21769/bioprotoc.1984
8. Muke S, Kaikini A, Peshattiwar V, Bagle S, Dighe V and Sathaye S (2018) Neuroprotective Effect of Coumarin Nasal Formulation: Kindling Model Assessment of Epilepsy. Front. Pharmacol. 9:992. doi: 10.3389/fphar.2018.00992”

Downloads

Published

2020-01-21

How to Cite

Tathe, M. . (2020). In vitro study of methanolic extract of Eclipta alba Hassk. FOR hepg2 cell line. Ayurline: International Journal of Research in Indian Medicine, 4(01). Retrieved from https://www.ayurline.in/index.php/ayurline/article/view/293

Issue

Vol. 4 No. 01 (2020): Ayurline: IJ-RIM | January - 2020

Section

Original Research Articles

License

I  declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurline.in and online filled (uploaded) form.

Please read following declaration cum Agreement Carefully.:

I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein.

I (We) agree (on behalf of me and my co-authors) to the following:

1- I (we) hereby assign to the publisher of the journal. Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) the right to (Electronically and print) publish on website www.ayurline.in and distribute the said manuscript and to create a derivative print work from the said manuscript. The assignment shall be effective so long as the manuscript is available on online networks.

2- I (we) shall remain the owner of the copyright in said manuscript. I (we) may publish the manuscript in any other journal or medium but such publication must include the notice that the manuscript was first published by Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journals including reference to the corresponding issue.

3- I (we) agree to hold the publisher of the Journal, Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) harmless for any unauthorized use of the paper by the journal subscribers.

4- I (we) confirm that I (we) have obtained all the necessary all permissions to include in the paper items such as quotations, figures, and the results of government-sponsored research/private or individual publishers/owners.

5- I (we) enclose where necessary written permission of authors and publishers to use any copyright material (previously published figures and tables).

6- I (we) confirm that after the publication of my (our) manuscript in Ayurline: International Journal of Research in Indian Medicine (IJ-RIM), the publisher has the sole authority of the paper/Research Article. The publisher has the authority to use the content of the whole paper or part of it, in an edited book, or other mediums or withdraw (unpublish) the article without the permission of authors.

8- If I / We found victims of plagiarism, (साहित्यिक चोरी) (e.g. text, images, videos etc.) I/ We sole responsible for such legal matters. I/We also declared that the Chief Editor/Publisher, Editorial Board of this Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journal does not have any responsibility for plagiarism. Publisher shall not become any party in any legal matter and if any case is filed in court against plagiarisms or any copyright-related issues all expenses/Penalties should be paid/borne by me/we (Authors). I shall be obliged to pay all the costs of the court case if any happened in future.

7 -I voluntarily agreed to pay the necessary non-refundable evaluation fees of the my article, which are not the publication Charges.  

8 - All disputes subject to Kurla, Mumbai court jurisdiction. This Copyright Licensing Agreement comes into force the day of sending this completed electronic form.